Please assess the completion status of the following clinical trial:

Trial Title: FFA-Induced Hypertension and Endothelial Dysfunction

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Males or females between the ages of 18 and 65 years.~* Definition: obese = BMI ≥ 30 kg/m2~* Blood pressure \< 140/80 mm Hg and no prior history of hypertension~Exclusion Criteria:~* History of hypertension or previous history of antihypertensive drug therapy.~* Current tobacco use~* Fasting triglyceride levels \> 250 mg/dL during the stabilization period.~* Liver disease (ALT 2.5x \> upper limit of normal), or other significant medical or surgical illness, including myocardial ischemia, congestive heart failure, liver failure, and infectious processes.~* Serum creatinine ≥1.5 mg/dL for males, or ≥ 1.4 mg/dL for females.~* History of drug or alcohol abuse within the last 5 years.~* Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study.~* Female subjects are pregnant or breast feeding at time of enrollment into the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Intralipid 20%@ 20cc/hour (Type: ACTIVE_COMPARATOR): Intralipid 20% IV infusion at 20cc/hour
- Intralipid 20% @ 40cc/hour (Type: ACTIVE_COMPARATOR): Intralipid 20% IV infusion at 40cc/hour
- Normal Saline infusion @ 40cc/hour (Type: PLACEBO_COMPARATOR): Normal Saline continuous IV infusion at 40cc/hour for 8 hours
- 32-gram oral fat load (Type: ACTIVE_COMPARATOR): 32-gram oral fat load once
- 64-gram oral fat load (Type: ACTIVE_COMPARATOR): 64-gram oral fat load once

Based on this trial design, predict the completion outcome and termination type (if applicable).